Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Heart Motion Powers Novel Cardiac Pacemaker

By HospiMedica International staff writers
Posted on 17 Sep 2014
A prototype batteryless pacemaker is based on an automatic wristwatch winding movement, with all unnecessary parts removed to reduce weight and size.

Developed by Adrian Zurbuchen, a PhD candidate in the cardiovascular engineering group at the University of Bern (Switzerland), the prototype works the same way it would on a person’s wrist; when exposed to an external acceleration, the eccentric mass of the clockwork starts rotating. More...
This rotation progressively winds a mechanical spring, which unwinds once fully charged, spinning an electrical microgenerator and electronic circuit to charge a small buffer capacity. The researchers also developed a custom-made housing with eyelets that allows suturing the device directly onto the myocardium.

To test the prototype, the researchers connected it to a custom-made cardiac pacemaker which was implanted in domestic pigs. The combined system first harvested the acquired energy from the heart; the energy was then temporarily stored in the buffer capacity; and finally, the buffered energy was used by the pacemaker to stimulate to the heart. The pacemaker allowed the researchers to pace the pigs’ hearts at 130 beats per minute. The prototype device was presented at the annual European Society of Cardiology (ESC) congress, held during August-September 2014 in Barcelona (Spain).

“The heart seems to be a very promising energy source because its contractions are repetitive and present for 24 hours a day, 7 days a week. Furthermore, the automatic clockwork, invented in the year 1777, has a good reputation as a reliable technology to scavenge energy from motion,” said Adrian Zurbuchen. “The next step in our prototype is to integrate both the electronic circuit for energy storage and the custom-made pacemaker directly into the harvesting device. This will eliminate the need for leads.”

“Our new pacemaker tackles the two major disadvantages of today’s pacemakers. First, pacemaker leads are prone to fracture and can pose an imminent threat to the patient. And second, the lifetime of a pacemaker battery is limited,” added Mr. Zurbuchen. “Our energy harvesting system is located directly on the heart and has the potential to avoid both disadvantages by providing the world with a batteryless and leadless pacemaker.”

Related Links:

University of Bern



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.